Click on photo to enlarge. You MAY share this image.  Recruiting Epi-Dogs for Canine Keppra Extended Release Pharmacokinetic Study Recruitment is open for dogs with epilepsy that are being treated with Keppra XR (levetiracetam extended release)) and Phenobarbital (group I) Keppra XR and Zonisamide (Zonegran) (group II) , or Keppra XR alone (group III) for a Pharmacokinetic study. This study is being conducted at North Carolina State University-College of Veterinary Medicine , under the direction of Dr. Karen Muñana, DVM, DACVIM (Neurology). If your dog has been diagnosed with epilepsy, and is receiving the drugs listed above in any of the 3 groups listed, we are interested in sampling your pet to determine how Keppra XR interacts with the other anticonvulsants through sequential blood sampling in a one-day study. All blood levels will be provided to the owners at no-charge. If you are interested in more information regarding this project, or to see if your pet ...